(Q54373873)

28 May 2018

title

Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis. (English)

1 reference

28 May 2018

1 reference

Lee SS

1

1 reference

28 May 2018

Moreau R

2

1 reference

28 May 2018

Hadengue A

3

1 reference

28 May 2018

Cerini R

4

1 reference

28 May 2018

Koshy A

5

1 reference

28 May 2018

Lebrec D

6

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 November 1988

1 reference

28 May 2018

published in

Hepatology

1 reference

28 May 2018

volume

8

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

1501-1505

1 reference

28 May 2018

Some statistical methods useful in circulation research.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

Effects of nitroglycerin on forearm haemodynamics in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Splanchnic Hemodynamic Responses to Glucagon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

The effect of glucagon on hepatic blood flow. An experimental study in the dog

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Inability of glucagon to increase glomerular filtration rate in dogs with experimental cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Secretion and degradation of insulin and glucagon in carbon tetrachloride-induced liver injury rats.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Elevated plasma glucagon levels in cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

The mediastinum in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Oxygen and bile acid content in the azygos blood

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Role of glucagon in splanchnic hyperemia of chronic portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Portal hemodynamics during nitroglycerin administration in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Elevation of plasma epinephrine levels produced by glucagon in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

The mechanism of glucagon-induced natriuresis in dogs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Importance of the liver during glucagon-mediated increases in canine renal hemodynamics.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Modification by glucagon of the splanchnic vascular responses to activation of the sympathicoadrenal system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080606

7 January 2021

Identifiers

DOI

10.1002/HEP.1840080606

1 reference

28 May 2018

1 reference

28 May 2018